Macquarie Group LTD Sanofi Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

A detailed history of Macquarie Group LTD transactions in Sanofi stock. As of the latest transaction made, Macquarie Group LTD holds 328,263 shares of SNY stock, worth $18.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

328,263

Previous 713,078 53.97%

Holding current value

$18.9 Million

Previous $34.7 Million 54.04%

% of portfolio

0.02%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$45.39 - $50.36 $17.5 Million - $19.4 Million	-384,815 Reduced 53.97%	328,263 $15.9 Million
Q1 2024 May 14, 2024	SELL	$45.75 - $52.48 $3.6 Million - $4.13 Million	-78,692 Reduced 9.94%	713,078 $34.7 Million
Q4 2023 Feb 14, 2024	SELL	$43.13 - $54.79 $17.2 Million - $21.9 Million	-399,662 Reduced 33.54%	791,770 $39.4 Million
Q3 2023 Nov 14, 2023	SELL	$50.95 - $55.2 $1.11 Million - $1.21 Million	-21,841 Reduced 1.8%	1,191,432 $63.9 Million
Q2 2023 Aug 14, 2023	SELL	$50.45 - $57.18 $1.24 Million - $1.4 Million	-24,485 Reduced 1.98%	1,213,273 $65.4 Million
Q1 2023 May 15, 2023	SELL	$45.86 - $54.45 $10.8 Million - $12.8 Million	-234,514 Reduced 15.93%	1,237,758 $67.4 Million
Q4 2022 Feb 21, 2023	SELL	$38.86 - $48.55 $1.14 Million - $1.43 Million	-29,407 Reduced 1.96%	1,472,272 $71.3 Million
Q3 2022 Nov 14, 2022	SELL	$37.22 - $100.5 $40.3 Million - $109 Million	-1,083,142 Reduced 41.9%	1,501,679 $57.1 Million
Q2 2022 Aug 15, 2022	SELL	$48.99 - $57.46 $1.23 Million - $1.44 Million	-25,132 Reduced 0.96%	2,584,821 $129 Million
Q1 2022 May 16, 2022	BUY	$48.48 - $53.65 $438,065 - $484,781	9,036 Added 0.35%	2,609,953 $134 Million
Q4 2021 Feb 11, 2022	SELL	$47.07 - $52.35 $8.85 Million - $9.84 Million	-188,043 Reduced 6.74%	2,600,917 $130 Million
Q3 2021 Nov 12, 2021	SELL	$47.89 - $53.12 $653,985 - $725,406	-13,656 Reduced 0.49%	2,788,960 $134 Million
Q2 2021 Aug 13, 2021	SELL	$49.36 - $54.25 $12.6 Million - $13.8 Million	-254,325 Reduced 8.32%	2,802,616 $148 Million
Q1 2021 May 14, 2021	BUY	$45.46 - $50.51 $10.9 Million - $12.2 Million	240,813 Added 8.55%	3,056,941 $151 Million
Q4 2020 Feb 16, 2021	SELL	$45.3 - $51.62 $3.61 Million - $4.11 Million	-79,694 Reduced 2.75%	2,816,128 $137 Million
Q3 2020 Nov 13, 2020	SELL	$49.47 - $53.77 $4.27 Million - $4.64 Million	-86,303 Reduced 2.89%	2,895,822 $145 Million
Q2 2020 Aug 11, 2020	SELL	$42.91 - $52.5 $5.25 Million - $6.43 Million	-122,462 Reduced 3.94%	2,982,125 $152 Million
Q1 2020 May 15, 2020	SELL	$38.02 - $51.66 $1.81 Million - $2.45 Million	-47,519 Reduced 1.51%	3,104,587 $136 Million
Q4 2019 Feb 14, 2020	SELL	$44.25 - $50.86 $1.35 Million - $1.55 Million	-30,489 Reduced 0.96%	3,152,106 $158 Million
Q3 2019 Nov 14, 2019	SELL	$40.34 - $46.64 $2.45 Million - $2.84 Million	-60,804 Reduced 1.87%	3,182,595 $147 Million
Q2 2019 Aug 14, 2019	SELL	$40.43 - $44.3 $669,844 - $733,962	-16,568 Reduced 0.51%	3,243,399 $140 Million
Q1 2019 May 15, 2019	BUY	$40.83 - $45.43 $3.95 Million - $4.4 Million	96,849 Added 3.06%	3,259,967 $144 Million
Q4 2018 Feb 15, 2019	SELL	$41.48 - $45.59 $9.43 Million - $10.4 Million	-227,303 Reduced 6.7%	3,163,118 $137 Million
Q3 2018 Nov 15, 2018	BUY	$40.0 - $44.84 $13.8 Million - $15.4 Million	344,140 Added 11.3%	3,390,421 $151 Million
Q2 2018 Aug 14, 2018	SELL	$37.63 - $41.22 $1.12 Million - $1.22 Million	-29,658 Reduced 0.96%	3,046,281 $122 Million
Q1 2018 May 11, 2018	BUY	$38.98 - $45.76 $17 Million - $20 Million	437,098 Added 16.56%	3,075,939 $123 Million
Q4 2017 Feb 15, 2018	BUY	$42.86 - $50.61 $705,047 - $832,534	16,450 Added 0.63%	2,638,841 $113 Million
Q3 2017 Nov 08, 2017	BUY	$47.04 - $50.34 $123 Million - $132 Million	2,622,391	2,622,391 $131 Million

Others Institutions Holding SNY

# of Institutions

794

Shares Held

252M

Call Options Held

2.6M

Put Options Held

1.64M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $145B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Sanofi Transaction History